EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?

Lisa Götz, Uwe Rueckschloss, Sonia M Najjar, Süleyman Ergün, Florian Kleefeldt iD

European Journal of Clinical Investigation · 2024

DOI: 10.1111/eci.14337 ↗

At a glance

Übersichtsarbeit in European Journal of Clinical Investigation, 2024. Written by Lisa Götz and 4 co-authors. Institution: Institute of Anatomy and Cell Biology, University of Wuerzburg, Wuerzburg, Germany. Major MEDLINE topics: Cell Adhesion Molecules, Neoplasms, Antigens, CD, Tumor Microenvironment. Cited 7 times so far (Crossref); 137 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Open Access Publication Fund of the University of Würzburg, Cancer Research Advancement Foundation, Walter Schulz Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The Carcinoembryonic antigen‐related cell adhesion molecule 1 (CEACAM1, also CD66a), a transmembrane glycoprotein of the immunoglobulin superfamily, is a pivotal mediator of various physiological and pathological processes, including oncologic disorders. However, its precise role in tumorigenicity is contradictory discussed by several clinical studies. This review aims to elucidate the clinical significance of CEACAM1 in different cancer entities focusing on tumour formation, progression and metastasis as well as on CEACAM1‐mediated treatment resistance. Furthermore, we discuss the contribution of CEACAM1 to cancer immunity and modulation of the inflammatory microenvironment and finally provide a comprehensive review of treatment regimens targeting this molecule.

Subjects

MeSH terms (MEDLINE)

Cell Adhesion MoleculesNeoplasmsAntigens, CDTumor MicroenvironmentHumansDrug Resistance, NeoplasmDisease ProgressionNeoplasm MetastasisCEACAM1 Protein

Author keywords

CD66aCEACAM1cancerinflammationtumorigenicitytumour microenvironment

Substances

CD66 antigensCell Adhesion MoleculesAntigens, CDCEACAM1 Protein

Authors and institutions

  • Institute of Anatomy and Cell Biology, University of Wuerzburg, Wuerzburg, Germany.
  • Department of Biomedical Sciences, Heritage College of Osteopathic Medicine Irvine Hall, Ohio University, Athens, Ohio, USA.

ORCID profiles: Florian Kleefeldt

Funding

  • Open Access Publication Fund of the University of Würzburg
  • Cancer Research Advancement Foundation
  • Walter Schulz Foundation

Cite

APA

Götz, L., Rueckschloss, U., Najjar, S. M., Ergün, S., & Kleefeldt, F. (2024). Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14337

Vancouver

Götz L, Rueckschloss U, Najjar SM, Ergün S, Kleefeldt F. Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14337

BibTeX
@article{Gtz2024,
  author = {Götz, Lisa and Rueckschloss, Uwe and Najjar, Sonia M and Ergün, Süleyman and Kleefeldt, Florian},
  title = {Carcinoembryonic antigen‐related cell adhesion molecule 1 in cancer: Blessing or curse?},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1111/eci.14337}
}
Start for free →